Cargando…
Clinical value of second opinions in oncology: A retrospective review of changes in diagnosis and treatment recommendations
BACKGROUND: Data on the clinical value of second opinions in oncology are limited. We examined diagnostic and treatment changes resulting from second opinions and the expected impact on morbidity and prognosis. METHODS: This retrospective cohort study included patients presenting in 2018 to a high‐v...
Autores principales: | Lipitz‐Snyderman, Allison, Chimonas, Susan, Mailankody, Sham, Kim, Michelle, Silva, Nicholas, Kriplani, Anuja, Saltz, Leonard B., Sihag, Smita, Tan, Carlyn Rose, Widmar, Maria, Zauderer, Marjorie, Weingart, Saul, Perchick, Wendy, Roman, Benjamin R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134380/ https://www.ncbi.nlm.nih.gov/pubmed/36737878 http://dx.doi.org/10.1002/cam4.5598 |
Ejemplares similares
-
Electronic consent in clinical care: an international scoping review
por: Chimonas, Susan, et al.
Publicado: (2023) -
Persistence of Telemedicine Usage for Breast and Prostate Cancer after the Peak of the COVID-19 Pandemic
por: Chimonas, Susan, et al.
Publicado: (2023) -
Association between cancer‐specific adverse event triggers and mortality: A validation study
por: Weingart, Saul N., et al.
Publicado: (2020) -
Developing a cancer‐specific trigger tool to identify treatment‐related adverse events using administrative data
por: Weingart, Saul N., et al.
Publicado: (2020) -
Why Not? Persuading Clinicians to Reduce Overuse
por: Chimonas, Susan C., et al.
Publicado: (2020)